SCHEMBL31063009

SCHEMBL31063009

CCc1cc(F)c(OC)c(B(O)O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.46
HTR2A P28223 4/20 0.35
HTR2C P28335 4/20 0.35
HTR1A P08908 3/20 0.35
DRD2 P14416 3/20 0.35
DRD4 P21917 3/20 0.35
DRD3 P35462 3/20 0.35
DBH P09172 1/20 0.35
LPL P06858 1/20 0.34
LIPG Q9Y5X9 1/20 0.34
TUBB1 Q9H4B7 6/20 0.33
TUBB4A P04350 2/20 0.31
TUBB P07437 2/20 0.31
TUBA3C P0DPH7 2/20 0.31
TUBA1B P68363 2/20 0.31
TUBA4A P68366 2/20 0.31
TUBB4B P68371 2/20 0.31
TUBB3 Q13509 2/20 0.31
TUBB2A Q13885 2/20 0.31
TUBB8 Q3ZCM7 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17616964 0.86 MAPT (0.42) HTR2AHTR2CDBHTUBB1TUBB4A
SCHEMBL31063030 0.84 DBH (0.34) HTR2AHTR2CDBHTUBB1TUBB4A
SCHEMBL4547651 0.82 PTGS2 (0.58) PTGS2HTR2AHTR2CHTR1ADRD2
SCHEMBL31063061 0.81 LMNA (0.40) DBH
SCHEMBL31063276 0.79 MEN1 (0.36) HTR2CHTR1A
SCHEMBL31063204 0.78 POLB (0.51)
SCHEMBL2467633 0.77 TUBB1 (0.34) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL31063268 0.76 SIGMAR1 (0.44) DRD3DBH
SCHEMBL31063422 0.76 ACHE (0.40) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL17622095 0.76 TAAR1 (0.41) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665339-A1 INHIBITING ALPHA V BETA 8 INTEGRIN Morphic Therapeutic, Inc. (US) 2025-12-24 EP disclosed
WO-2024173570-A1 INHIBITING αvβ8 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2024-08-22 WO disclosed